RxAll
PrivateLast Round
Seed
Jul 20, 2021
Total Funding Raised
$4.74M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Oval Medical Technologies Ltd is a medical products company that specializes in the design and development of injectable drug delivery devices, including autoinjectors.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Medical Devices, Supply Chain, Healthcare Analytics
Business Model
B2B
Customer Profile
Marketplace Commission, Hardware Sales, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxAll Comparables
Compare RxAll with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Meditect | 79% | |
| Sproxil | 75% | |
| Chekkit Technologies | 75% |
RxAll Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 20, 2021 | ||||
| Pre Seed | Nov 1, 2020 | ||||
| Accelerator | Sep 21, 2020 | ||||
| Grant | Mar 27, 2019 | ||||
| Accelerator | Jun 1, 2018 | ||||
Grant | Apr 1, 2017 |
RxAll Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch Africa Ventures | Seed |
| Katapult Accelerator | Accelerator |
| Standard Bank Group | Accelerator |
| Yale University | Grant |
| Founders Factory Africa | Accelerator |
| Hello Tomorrow | Grant |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 9, 2.3x the trailing average.
- Jul 25, 2026
Monthly visitors increased 453% MoM, reaching 4.9K.
RxAll Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RxAll's valuation, stock price, and market status.
Is RxAll a public or private company?
RxAll is a private company.
What is the current stock price of RxAll?
RxAll is a private company, so its shares have no public market price. Caplight tracks RxAll's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RxAll worth (valuation)?
Valuation information for RxAll is not publicly available.
Can I buy RxAll stock?
RxAll shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RxAll's last funding round?
RxAll's most recent funding round was Seed on July 20, 2021.
Who are the main investors in RxAll?
Key investors in RxAll include Launch Africa Ventures, Founders Factory Africa, SOSV, HAX.
Will RxAll IPO soon?
No public IPO plans have been announced for RxAll.
How can I track RxAll secondary market activity?
Caplight tracks bids, offers, and trades in RxAll's shares on secondary markets.